Evidence map›Paper›PMID 28761821›Full record

ArticleAdvanced pharmaceutical bulletin2017

Pharmacokinetic Parameters and Over-Responsiveness of Iranian Population to Propranolol.

Ebrahim Salehifar, Shima Ebrahim, Mohammad-Reza Shiran, Fatemeh Faramarzi, Hossein Askari Rad, Razieh Avan, Asadollah Mohseni Kiasari, Pouneh Ebrahimi

Open access · diamondAbstract read
In one paragraph

Article in Advanced pharmaceutical bulletin, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.6field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 4 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Ebrahim SalehifarPharmaceutical Research Center, Faculty of Pharmacy, Mazandaran University of Medical Sciences, Sari, Iran.
Shima EbrahimStudent Research Committee, Faculty of Pharmacy, Mazandaran University of Medical Sciences, Sari, Iran.
Mohammad-Reza ShiranImmunogenetics Research Center, Faculty of Medicine, Mazandaran University of Medical Sciences, Sari, Iran.
Fatemeh FaramarziStudent Research Committee, Department of Clinical Pharmacy, Mazandaran University of Medical Sciences, Sari, Iran.
Hossein Askari RadFaculty of Pharmacy, Mazandaran University of Medical Sciences, Sari, Iran.
Razieh AvanStudent Research Committee, Department of Clinical Pharmacy, Mazandaran University of Medical Sciences, Sari, Iran.
Asadollah Mohseni KiasariFaculty of Medicine, Mazandaran University of Medical Sciences, Sari, Iran.
Pouneh EbrahimiDepartment of Chemistry, Faculty of Basic Sciences, Golestan University, Gorgan, Iran.
Mazandaran University of Medical Sciences · IRGolestan University · IR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Iranian PopulationPharmacodynamicPharmacokineticsPolymorphismPropranolol

Identifiers

PMID28761821
PMCPMC5527233
OpenAlexW2726048363

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.